Measslainte

Using the EMA's own BWP position paper (released under ASK-289849) and the public GenBank deposit OR134577.1, an independent annotation of the BNT162b2 plasmid. The SV40 footprint is 695 bp, the backbone traces to the 1981 pSV2 vector family, and the integration property has been documented for 45 years.

Guide to nobiletin and eriodictyol, potent citrus flavonoids that combat inflammation, support antioxidant defenses, and attenuate endotoxin-induced inflammatory signaling.

Your biology is unique. What helps one person recover may not help you or could make things worse. This framework guides you through systematic assessment and targeted interventions based on your specific health terrain.

The site's forensics cluster documents what got into the vials. The persistence cluster documents what spike does once it is made. The missing layer has always been the particle itself. This article assembles the lipid-nanoparticle evidence: how LNPs acquire a biological identity in lymph and plasma, why distribution follows capillary anatomy rather than diffusion, what the regulatory and published pharmacokinetic studies actually measured, why the empty fraction of every batch is biologically active, and what the Gutschi, Seger and Seneff active-biointerface review proposes. Every load-bearing claim carries a verified primary source.

A six-ground retraction request against Andersen et al. (2020), 'The proximal origin of SARS-CoV-2', under the COPE guidelines, prepared for Nature Medicine and published here before it is filed. The documentary case rests on the July 2026 Senate release of the authors' private Slack channel and the Baric transcribed interview. Spun out from the Pinsolle Framework article, where the underlying evidence is presented.

Detection is not clearance. A December 2025 Stanford paper places EPO-EPOR signalling on type 1 conventional dendritic cells as the master switch between immune tolerance and immune activation. Read alongside the cGAS-STING DNA-sensing literature, it suggests an uncomfortable hypothesis: contaminant plasmid DNA in mRNA vaccines may be detected loudly and cleared quietly, because the tolerance gate downstream is open.

A companion to the spikeopathy pathways article. Five mechanism-based subtypes instead of one umbrella hypothesis, a four-tier UK biomarker matrix mapped to each subtype, and an explicit falsifiability section. The differentiator: nobody has tried comprehensive PASC subtyping by clearance/tolerance mechanism before.

The clearance-system failure hypothesis of spikeopathy. Two systems break together: mTOR-driven autophagy inside cells, and glymphatic flow between them. SIRT1/PGC-1α is the connecting axis. With 2025 DTI-ALPS imaging, the dual-mTOR model, and the levers that actually touch the cycle.

Correction, 4 October 2026. This article was first published 4 June 2026 with errors, corrected here against the source papers. The Marks paper was dated 2025; it was published 29 April 2026. Its senior author was attributed to the Weissman lab; the work is from Brian Brown's group at Mount Sinai. "Mört" was a misspelling; the first author is Mörz. The frameshifting rate was given as 0.5 to 1 percent; the paper reports frameshifted product at about 8 percent of in-frame reporter protein. The two autopsy findings were labelled "confirmed autoimmune myocarditis" and "confirmed autoimmune hepatitis"; the paper reports borderline histio-lymphocytic myocarditis in one case and chronic hepatitis in the context of pre-existing primary biliary cirrhosis in the other. The miRT origin paper was cited to Nature Biotechnology; it is Nature Medicine 2006. Overstated framing throughout was rewritten to what the papers show. ...

Comprehensive computational analysis reveals artificial codon preference changes in COVID-19 mRNA vaccines (Pfizer: 15%, Moderna: 35%) absent from all natural SARS-CoV-2 variants (0%).

Correction, 4 October 2026. This article was first published 29 March 2026 claiming to validate Jean-Claude Perez's 2020 numerical observation. The following claims are withdrawn. The "82.6 percent validation" figure was a ratio of two percentage differences (26.1 divided by 31.6), which is not a validation metric. The Z-scores of 68 to 91 were artifacts of comparing viral genes against a housekeeping-gene baseline (22.1±3.4 ruptures/kb) that every viral sequence violates by two orders of magnitude; they are not quotable, and the article's own results table was irreconcilable with that baseline. "All natural viruses use -1 PRF" is false: programmed +1 frameshifting exists in nature, the bacterial release-factor-2 gene prfB being the standard textbook example. The "8-10 percent frameshifting efficiency" figure misstated Mulroney et al. (2024), which reports frameshifted product at about 8 percent of in-frame reporter protein in a reporter construct, not a translation rate; the same correction was applied to two other articles on this site the same day. The gain-of-function framing was wrong: the 2P substitutions are published, intentional prefusion-stabilisation design, and the product is a vaccine, not a virus. A melanoma tumour-growth claim attributed to Rubio-Casillas et al. was removed as unverified against the paper, which is a narrative review. A "Monroe et al. 2024" reference could not be traced and is removed. An "A-" self-grade and a "new scientific contribution" claim are removed. What survives is below, stated at the strength the evidence bears. ...